BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,975,286
- Total 13F shares
- 159,820,679
- Share change
- -3,110,719
- Total reported value
- $12,448,675,606
- Put/Call ratio
- 99%
- Price per share
- $77.80
- Number of holders
- 386
- Value change
- -$243,125,240
- Number of buys
- 198
- Number of sells
- 153
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
8.2%
|
15,853,295
|
$1,307,580,000 | — | 31 Mar 2016 | |
| FMR LLC |
13F
|
Company |
7%
|
13,459,463
|
$1,110,136,000 | — | 31 Mar 2016 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6%
|
11,561,504
|
$953,593,000 | — | 31 Mar 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
11,102,321
|
$915,720,000 | — | 31 Mar 2016 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
4.5%
|
8,749,891
|
$721,691,000 | — | 31 Mar 2016 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
3.8%
|
7,350,369
|
$606,258,000 | — | 31 Mar 2016 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.2%
|
6,218,760
|
$512,923,000 | — | 31 Mar 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.5%
|
4,806,483
|
$396,439,000 | — | 31 Mar 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.3%
|
4,486,438
|
$370,041,000 | — | 31 Mar 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
2%
|
3,809,516
|
$314,209,000 | — | 31 Mar 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.9%
|
3,683,333
|
$303,801,000 | — | 31 Mar 2016 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.8%
|
3,472,712
|
$286,429,000 | — | 31 Mar 2016 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
3,286,743
|
$271,074,000 | — | 31 Mar 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.4%
|
2,656,812
|
$219,134,000 | — | 31 Mar 2016 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
2,464,645
|
$203,285,000 | — | 31 Mar 2016 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
2,194,875
|
$181,033,000 | — | 31 Mar 2016 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.97%
|
1,867,384
|
$154,022,000 | — | 31 Mar 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.8%
|
1,545,384
|
$127,463,000 | — | 31 Mar 2016 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.77%
|
1,489,137
|
$122,824,000 | — | 31 Mar 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.76%
|
1,464,429
|
$120,786,000 | — | 31 Mar 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.71%
|
1,360,890
|
$112,246,000 | — | 31 Mar 2016 | |
| Palo Alto Investors LP |
13F
|
Company |
0.69%
|
1,340,347
|
$110,552,000 | — | 31 Mar 2016 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.69%
|
1,340,066
|
$110,529,000 | — | 31 Mar 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.69%
|
1,335,264
|
$110,128,000 | — | 31 Mar 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.68%
|
1,311,159
|
$108,144,000 | — | 31 Mar 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
1,165,877
|
$103,319,000 | — | 31 Mar 2016 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.64%
|
1,239,284
|
$102,217,000 | — | 31 Mar 2016 | |
| TCW GROUP INC |
13F
|
Company |
0.61%
|
1,178,390
|
$97,194,000 | — | 31 Mar 2016 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.59%
|
1,147,639
|
$94,658,000 | — | 31 Mar 2016 | |
| NORGES BANK |
13F
|
Company |
0.58%
|
1,110,261
|
$91,575,000 | — | 31 Mar 2016 | |
| BlackRock Group LTD |
13F
|
Company |
0.57%
|
1,100,764
|
$90,792,000 | — | 31 Mar 2016 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.55%
|
1,052,900
|
$86,843,000 | — | 31 Mar 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.54%
|
1,038,437
|
$85,651,000 | — | 31 Mar 2016 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.54%
|
1,035,795
|
$85,432,000 | — | 31 Mar 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.53%
|
1,023,200
|
$84,394,000 | — | 31 Mar 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.52%
|
1,010,910
|
$83,334,000 | — | 31 Mar 2016 | |
| Blue Ridge Capital, L.L.C. |
13F
|
Company |
0.52%
|
1,000,000
|
$82,480,000 | — | 31 Mar 2016 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.52%
|
997,098
|
$82,241,000 | — | 31 Mar 2016 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
985,168
|
$81,257,000 | — | 31 Mar 2016 | |
| Amici Capital, LLC |
13F
|
Company |
0.46%
|
886,419
|
$73,112,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
844,307
|
$69,639,000 | — | 31 Mar 2016 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.33%
|
635,807
|
$52,441,000 | — | 31 Mar 2016 | |
| Legal & General Group Plc |
13F
|
Company |
0.33%
|
633,281
|
$52,233,000 | — | 31 Mar 2016 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.32%
|
612,861
|
$50,548,000 | — | 31 Mar 2016 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.31%
|
602,116
|
$49,663,000 | — | 31 Mar 2016 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.31%
|
596,145
|
$49,170,000 | — | 31 Mar 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.29%
|
560,201
|
$46,206,000 | — | 31 Mar 2016 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.29%
|
555,319
|
$45,803,000 | — | 31 Mar 2016 | |
| FIL Ltd |
13F
|
Company |
0.27%
|
511,397
|
$42,180,000 | — | 31 Mar 2016 | |
| Senator Investment Group LP |
13F
|
Company |
0.26%
|
500,000
|
$41,240,000 | — | 31 Mar 2016 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q2 2016
As of 30 Jun 2016,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
386 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
159,820,679 shares.
The largest 10 holders included
Capital Research Global Investors, VANGUARD GROUP INC, FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
386
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
379
Q2 2016 holders
386
Holder diff
7
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.